Kazakhstan vs Malaysia: Adults (ages 15+) and children (ages 0-14) newly infected with HIV
Kazakhstan
2,300
in 2024
Malaysia
2,700
in 2024
Kazakhstan rank
54th
Malaysia rank
51st
Adults (ages 15+) and children (ages 0-14) newly infected with HIV over time
- Kazakhstan
- Malaysia
How they compare
Malaysia currently reports 2,700 against 2,300 in Kazakhstan, a difference of 400.
That makes Malaysia's figure about 1.2 times Kazakhstan's.
Across all 35 years both countries report, Malaysia has been ahead every year.
Kazakhstan ranks 54th and Malaysia ranks 51st of 146 countries.
Malaysia has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Kazakhstan | Malaysia | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 282 | 5,530 | 5,248 | Malaysia |
| 2000s | 1,437 | 5,670 | 4,233 | Malaysia |
| 2010s | 2,680 | 4,630 | 1,950 | Malaysia |
| 2020s | 2,440 | 2,880 | 440 | Malaysia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher adults (ages 15+) and children (ages 0-14) newly infected with hiv, Kazakhstan or Malaysia?
- Malaysia, at 2,700 against 2,300 in Kazakhstan as of 2024.
- What is the difference in adults (ages 15+) and children (ages 0-14) newly infected with hiv between Kazakhstan and Malaysia?
- 400, with Malaysia ahead.
- How many years of comparable data are there for Kazakhstan and Malaysia?
- 35 years are reported by both, from 1990 to 2024.
- How do Kazakhstan and Malaysia rank globally for adults (ages 15+) and children (ages 0-14) newly infected with hiv?
- Kazakhstan ranks 54th and Malaysia ranks 51st of 146 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Adults (ages 15+) and children (ages 0-14) newly infected with HIV. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of adults (ages 15+) and children (ages 0-14) newly infected with HIV.